ARTICLE | Clinical News
Interneuron regulatory update
April 15, 2013 7:00 AM UTC
IPIC submitted an NDA to the FDA for CerAxon citicoline to treat ischemic stroke. The NDA is based on Phase III results announced last summer (see BioCentury Extra, July 16). ...